科伦药业：目前AI通过虚拟工程师调整实验罐发酵水平的效果已略高于未使用AI时的水平

Core Insights - The company, Kelun Pharmaceutical, announced that AI has improved the fermentation levels in production processes, surpassing the levels achieved without AI [1] - The production line for thiocyanate erythromycin is fully integrated with the AI system, with plans to quickly incorporate AI into cephalosporin and penicillin production lines [1] - Experimental results indicate that under the same material input, the average yield of AI-controlled fermentation tanks exceeds that of the control group by approximately 3% to 5% [1] - As batch numbers increase and iteration speeds accelerate, overall fermentation levels are expected to improve further [1] - In the field of synthetic biology, AI has significantly enhanced enzyme modification efficiency and activity, greatly improving research and development efficiency [1] - The company is gradually applying AI to various research and development tools, with expectations for AI to play a larger role in the R&D phase in the future [1]